866-997-4948(US-Canada Toll Free)

Global Gene Therapy Partnering Terms and Agreements 2010 to 2016

Published By :

Current Partnering

Published Date : Feb 2016

Category :

Therapeutic Area

No. of Pages : 240 Pages

The Global

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in Gene therapy dealmaking

2.1. Introduction
2.2. Gene therapy partnering over the years
2.3. Most active Gene therapy dealmakers
2.4. Gene therapy partnering by deal type
2.5. Gene therapy partnering by therapy area
2.6. Deal terms for Gene therapy partnering
2.6.1 Gene therapy partnering headline values
2.6.2 Gene therapy deal upfront payments
2.6.3 Gene therapy deal milestone payments
2.6.4 Gene therapy royalty rates

Chapter 3 – Leading Gene therapy deals

3.1. Introduction
3.2. Top Gene therapy deals by value

Chapter 4 – Most active Gene therapy dealmakers

4.1. Introduction
4.2. Most active Gene therapy dealmakers
4.3. Most active Gene therapy partnering company profiles

Chapter 5 – Gene therapy contracts dealmaking directory

5.1. Introduction
5.2. Gene therapy contracts dealmaking directory

Chapter 6 – Gene therapy dealmaking by technology type

Chapter 7 – Partnering resource center

7.1. Online partnering
8.2. Partnering events
8.3. Further reading on dealmaking


Appendix 1 – Gene therapy deals by company A-Z

Appendix 2 – Gene therapy deals by stage of development

Phase I
Phase II
Phase III

Appendix 3 – Gene therapy deals by deal type

Asset purchase
Bigpharma outlicensing
Collaborative R&D
Joint venture
Spin out
Technology transfer

Appendix 4 – Gene therapy deals by therapy area

Central Nervous System
Genetic disorders
Orphan disease

Appendix 5 –Deal type definitions

About Wildwood Ventures

Current Partnering
Current Agreements
Recent report titles from Current Partnering

List of Table


List of Chart

Table of figures

Figure 1: Gene therapy partnering since 2010
Figure 2: Active Gene therapy dealmaking activity– 2010 to 2016
Figure 3: Gene therapy partnering by deal type since 2010
Figure 4: Gene therapy partnering by disease type since 2010
Figure 5: Gene therapy deals with a headline value
Figure 6: Gene therapy deals with an upfront value
Figure 7: Gene therapy deals with a milestone value
Figure 8: Gene therapy deals with a royalty rate value
Figure 9: Top Gene therapy deals by value since 2010
Figure 10: Most active Gene therapy dealmakers 2010 to 2016
Figure 11: Online partnering resources
Figure 12: Forthcoming partnering events

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *

Upcoming Reports

  • Injectable Targeted Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020

    Targeted delivery is a clinical treatment used to deliver medication in patients to increase the concentration of medication in some parts of the body. Target specific drug delivery is localized, prolonged, targeted and have protected drug interaction with the diseased tissue. The advantage of injectable targeted therapy was the decrease in frequency of the dosages that are delivered to the patient, it more uniform effect of the drug, reduction o...

  • Proton Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

    Proton therapy is an advanced form of radiation therapy especially for cancer patients with significant advantages over conventional radiation therapy in terms of efficacy and unwanted side effects. In proton therapy a beam of protons is irradiated to diseased tissue with the help of a particle accelerator. These protons cause damage to targeted cells by interfering with their genetic functions. Protons, due to their large mass do not scatter sid...

  • Vena Cava Filters Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

    Inferior vena cava or posterior vena cava is the largest vein in the human body responsible for carrying de-oxygenated blood from the lower extremities of the body into the right atrium of heart and then to the lungs. Vena cava filter is a medical device designed to prevent blood clots from travelling to lungs. These filters are implanted by interventional radiologists or vascular surgeons and are used as prophylactic aid for pulmonary emboli. ...